Clinical Trial Update: Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV) [Phase 3]

View source ↗

Summary

Phase 3 trial update on nasal intermittent positive pressure ventilation (NIPPV) for respiratory insufficiency in premature infants; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Insufficiency of Prematurity

Drugs mentioned

• Nasal Intermittent Positive Pressure Ventilation (NIPPV)

Snippet

Sponsor: McMaster University | Conditions: Respiratory Insufficiency of Prematurity | Phase 3 | Status: COMPLETED